Pomanda estimates the enterprise value of NANDRA PHARMA LTD at £11.7k based on a Turnover of £29.3k and 0.4x industry multiple (adjusted for size and gross margin).
nandra pharma ltdEstimated Valuation
£0
Pomanda estimates the enterprise value of NANDRA PHARMA LTD at £0 based on an EBITDA of £-2k and a 3.09x industry multiple (adjusted for size and gross margin).
nandra pharma ltdEstimated Valuation
£495
Pomanda estimates the enterprise value of NANDRA PHARMA LTD at £495 based on Net Assets of £211 and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nandra Pharma LtdOverview
Nandra Pharma Ltd is a live company located in birmingham, B6 7DG with a Companies House number of 10017038. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2016, it's largest shareholder is
narvinder singh nandra
with a 100% stake. Nandra Pharma Ltd is a young,
micro sized company, Pomanda has estimated its turnover at
£29.3k with
declining
growth in recent years.
Pomanda's financial health check has awarded Nandra Pharma Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
Health Rating1out of 5
1 Strong
1 Regular
8 Weak
Size
annual sales of £29.3k, make it smaller than the average company (£640.8k)
£29.3k - Nandra Pharma Ltd
£640.8k - Industry AVG
Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (7.4%)
-5% - Nandra Pharma Ltd
7.4% - Industry AVG
Production
with a gross margin of 22.6%, this company has a higher cost of product (38.9%)
22.6% - Nandra Pharma Ltd
38.9% - Industry AVG
Profitability
an operating margin of -7% make it less profitable than the average company (5.5%)
-7% - Nandra Pharma Ltd
5.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (16)
1 - Nandra Pharma Ltd
16 - Industry AVG
Pay Structure
on an average salary of £26.2k, the company has an equivalent pay structure (£26.2k)
£26.2k - Nandra Pharma Ltd
£26.2k - Industry AVG
Efficiency
resulting in sales per employee of £29.3k, this is less efficient (£48.4k)
£29.3k - Nandra Pharma Ltd
£48.4k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is later than average (22 days)
50 days - Nandra Pharma Ltd
22 days - Industry AVG
Creditor Days
its suppliers are paid after 62 days, this is slower than average (18 days)
62 days - Nandra Pharma Ltd
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Nandra Pharma Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Nandra Pharma Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 94.8%, this is a higher level of debt than the average (26.3%)
94.8% - Nandra Pharma Ltd
26.3% - Industry AVG
NANDRA PHARMA LTD financials
EXPORT
Nandra Pharma Ltd's latest turnover from January 2024 is estimated at £29.3 thousand and the company has net assets of £211. According to their latest financial statements, Nandra Pharma Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Turnover
29,284
27,973
29,482
33,871
65,243
73,527
95,985
94,255
Other Income Or Grants
Cost Of Sales
22,678
21,931
23,449
27,002
51,148
57,930
74,209
70,736
Gross Profit
6,606
6,042
6,033
6,869
14,094
15,597
21,776
23,519
Admin Expenses
8,649
7,487
8,054
11,044
19,278
8,296
16,271
17,636
Operating Profit
-2,043
-1,445
-2,021
-4,175
-5,184
7,301
5,505
5,883
Interest Payable
Interest Receivable
Pre-Tax Profit
-2,043
-1,445
-2,021
-4,175
-5,184
7,301
5,505
5,883
Tax
-1,387
-1,046
-1,176
Profit After Tax
-2,043
-1,445
-2,021
-4,175
-5,184
5,914
4,459
4,706
Dividends Paid
Retained Profit
-2,043
-1,445
-2,021
-4,175
-5,184
5,914
4,459
4,706
Employee Costs
26,213
24,957
23,966
23,047
22,787
22,274
43,268
43,038
Number Of Employees
1
1
1
1
1
1
2
2
EBITDA*
-2,043
-1,445
-2,021
-4,175
-5,184
7,301
5,505
5,883
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Tangible Assets
2
187
329
115
380
645
631
840
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
2
187
329
115
380
645
631
840
Stock & work in progress
Trade Debtors
4,068
4,593
5,594
7,198
18,179
22,871
17,034
15,577
Group Debtors
Misc Debtors
Cash
misc current assets
total current assets
4,068
4,593
5,594
7,198
18,179
22,871
17,034
15,577
total assets
4,070
4,780
5,923
7,313
18,559
23,516
17,665
16,417
Bank overdraft
Bank loan
Trade Creditors
3,859
2,526
2,224
1,593
8,664
8,437
8,500
11,711
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
3,859
2,526
2,224
1,593
8,664
8,437
8,500
11,711
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
3,859
2,526
2,224
1,593
8,664
8,437
8,500
11,711
net assets
211
2,254
3,699
5,720
9,895
15,079
9,165
4,706
total shareholders funds
211
2,254
3,699
5,720
9,895
15,079
9,165
4,706
Jan 2024
Jan 2023
Jan 2022
Jan 2021
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Operating Activities
Operating Profit
-2,043
-1,445
-2,021
-4,175
-5,184
7,301
5,505
5,883
Depreciation
Amortisation
Tax
-1,387
-1,046
-1,176
Stock
Debtors
-525
-1,001
-1,604
-10,981
-4,692
5,837
1,457
15,577
Creditors
1,333
302
631
-7,071
227
-63
-3,211
11,711
Accruals and Deferred Income
Deferred Taxes & Provisions
Cash flow from operations
-185
-142
214
-265
-265
14
-209
841
Investing Activities
capital expenditure
185
142
-214
265
265
-14
209
-840
Change in Investments
cash flow from investments
185
142
-214
265
265
-14
209
-840
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest
cash flow from financing
cash and cash equivalents
cash
overdraft
change in cash
nandra pharma ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for nandra pharma ltd. Get real-time insights into nandra pharma ltd's credit score, group structure and payment trends.
Perform a competitor analysis for nandra pharma ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in B 6 area or any other competitors across 12 key performance metrics.
nandra pharma ltd Ownership
NANDRA PHARMA LTD group structure
Nandra Pharma Ltd has no subsidiary companies.
Ultimate parent company
NANDRA PHARMA LTD
10017038
NANDRA PHARMA LTD Shareholders
The sole shareholder of Nandra Pharma Ltd is Narvinder Singh Nandra.
narvinder singh nandra
100%
nandra pharma ltd directors
Nandra Pharma Ltd currently has 1 director, Mr Narvinder Nandra serving since Feb 2016.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to nandra pharma ltd.
nandra pharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NANDRA PHARMA LTD. This can take several minutes, an email will notify you when this has completed.
nandra pharma ltdCompanies House Filings - See Documents
